Andreas Gerward

Filings at 3 companies/Chief executive officer · Stayble Therapeutics AB

5 of 10 shown

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings by this filer, out of 10. Reading the whole list, and the full company page behind every filing, is part of the subscription. So are this filer’s key figures — how many filings and open-market purchases they reported, and over which period — and the price change beside each line, since the filing and since the trade. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The 5 most recent of 10 visible filings, newest first.

Stayble Therapeutics AB Chief executive officer
18,800 SEKOpen-market buy
TradedDec 6, 2024FiledDec 6, 2024
Stayble Therapeutics AB Chief executive officer
48,000 SEKOpen-market buy
TradedJun 12, 2024FiledJun 12, 2024
Stayble Therapeutics AB Chief executive officer
250,599 sharesOption exercise
TradedApr 12, 2023FiledApr 14, 2023
Stayble Therapeutics AB Chief executive officer
28,000 sharesOption exercise
TradedApr 12, 2023FiledApr 14, 2023
Stayble Therapeutics AB Chief executive officer
81,401 sharesOther
TradedMar 27, 2023FiledMar 27, 2023